13 | Hod5.79 R@30dma7.ish Yet I feel this could be | znewcar1 | 01/29/2024 1:35:07 PM |
12 | Knocking @5.71 afts5.6ish the BO6 then R@$2 then | znewcar1 | 01/29/2024 12:27:59 PM |
11 | PDSB Hod5.74 ML3.93 weekly chart thin in +> the | znewcar1 | 01/29/2024 11:40:36 AM |
10 | $PDSB 23% v2,7M c11.40 f28,5M H11.48 ML7.95 | znewcar1 | 12/28/2022 4:39:29 PM |
9 | PDSB 26% v30,8M c7.27 f22,2M | znewcar1 | 05/20/2021 5:44:18 PM |
8 | PDSB 53% v8,5M c6.81 f22,2M | znewcar1 | 02/09/2021 4:41:33 PM |
7 | PDSB .18% v2,3M c2.47 f22,2M | znewcar1 | 11/04/2020 7:11:15 PM |
6 | PDSB - Save the date - Oct 6th - Virtual roadshow | schoolofrock | 09/30/2020 1:57:12 PM |
5 | PDSB 39% v5,1M c4.19 f15,3M H4.37 gap with a | znewcar1 | 07/20/2020 6:15:25 PM |
4 | PDSB 20% v3,0M c3.01 f15,3M H3.36 | znewcar1 | 07/17/2020 11:53:22 PM |
3 | PDSB 33% v3,4M c2.72 f15,3M H2.88 EOD | znewcar1 | 07/15/2020 6:36:11 PM |
2 | PDSB 60% v36,7M c2.60 f15,3M gap up rip through | znewcar1 | 06/29/2020 8:18:47 PM |
1 | PDSB 31% v1,M c3.94 f5M IPO | znewcar1 | 10/03/2019 4:09:47 PM |
Recent Articles
- The Growth Journey of Dell Technologies Stock Over Five Years
- Veteran Author Fosters Community Connections Through Book Event
- Brookfield Announces Quarterly Distribution for Investors
- Launched Investigation into Lesaka Technologies for Shareholders
- Legal Guidance for CTO Realty Growth Investors Ahead of Deadline
- A Remarkable Journey: The Growth of Starbucks Over 20 Years
- Investors Have a Chance to Lead the Snap Inc. Lawsuit
- Innovative Hair Care Solutions from Magic Sleek for All Types
- Navigating Retirement: Rediscovering Purpose Beyond Work
- How a $1000 Investment in OSI Systems Could Flourish
- How $1000 in Cencora Became Over $6000 in Just 10 Years
- Onyx Gold Secures $15 Million in Strategic Financing Deal
- Investors Alert: Unicoin, Inc. Class Action Investigation
- Honoring Ryan Silver: A Leader in College Basketball Impact
- Leadership Changes at NanoXplore: A New Chapter Begins
- SelectQuote's Legal Challenges: What Investors Should Know
- G-P Recognized as a Pioneering Leader in EOR Solutions
- KinderCare Faces Legal Challenges Amid Child Safety Allegations
- Court's Ruling Protects Ontario's Water Supply from IEUA Deal
- Celebrating Leadership Excellence: David M. Sullivan II's Impact
- Celebrating Dr. Erica S. Becker: A Leading Oral Surgeon
- How Supplier Onboarding Shapes Long-Term Business Relationships
- Rosen Law Firm Urges Snap Inc. Investors to Take Action
- aTyr Pharma's Share Turmoil: Investigating the Miscommunication
- Turning Small Investments into Substantial Returns: F5's Journey
- Exploring BlackRock's Transition of Mutual Funds to ETFs
- How $100 in Lam Research Became a Remarkable Investment
- LifeMD Faces Class Action Lawsuit Over Misleading Claims
- Fair Trade Initiative Aims to Support U.S. Mushroom Farmers
- Nutex Health Under Fire: Investor Lawsuit Over Financial Misconduct
- Investor Concerns Rise Following Replimune's EUA Rejection
- LanzaJet Applauds Transformative Investment in Sustainable Fuels
- C3.ai Faces Class Action Claims Over Alleged Investor Misleading
- Del Sol Food Company Celebrates Heritage with Premium Coffee
- Understanding the Lantheus Holdings, Inc. Lawsuit for Investors
- Heavy Industry Practices That Minimize Climate Impact on Equipment
- Leadership Shift at NanoXplore: A New Era Begins
- Intermap Technologies Unveils Key Prospectus for Future Growth
- Performance Food Group Co: A Five-Year Stock Journey
- Understanding the Fluor Corporation Class Action Opportunity
- Analyzing BWX Technologies Inc: A Deep Dive into P/E Ratio
- Investors Urged to Join Charter Communications Securities Case
- Lantheus Holdings, Inc. Offers Insights into Legal Proceedings
- WWE Extends Academic Opportunities for Students at Full Sail
- Engage with CTO Realty Growth, Inc. Class Action Lawsuit Today
- Study Highlights Suicidal Risks Linked to Atopic Eczema
- Eli Lilly's Orforglipron Shows Promise in Weight Management
- Link Between Atopic Eczema and Increased Suicidal Thoughts
- Investors Join Together to Challenge Spectrum Pharmaceuticals
- Lockheed Martin Faces Class Action Over Financial Misconduct